catechin has been researched along with Nerve Pain in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores-Murrieta, FJ; Godínez-Chaparro, B; Granados-Soto, V; Pineda-Farias, JB; Quiñonez-Bastidas, GN; Reyes-García, JG; Rocha-González, HI; Rodríguez-Silverio, J | 1 |
| Bimonte, S; Cascella, M; Cuomo, A; Mehrabi-Kermani, F; Schiavone, V | 1 |
| Ferguson, SJ; Hausmann, O; Klasen, J; Konno, S; Krupkova, O; Sekiguchi, M; Wuertz-Kozak, K | 1 |
| Morgado, C; Pereira-Terra, P; Raposo, D; Tavares, I | 1 |
| Alberch, J; Boadas-Vaello, P; Puig, T; Turrado, C; Verdú, E; Vidal-Sancho, L; Xifró, X | 1 |
| Gu, HF; Guo, QL; Huang, Y; Kuang, X; Song, ZB; Zou, WY; Zu, XY | 1 |
| Choi, JI; Kim, WM; Kim, YO; Lee, HG; Yoon, MH | 1 |
1 review(s) available for catechin and Nerve Pain
| Article | Year |
|---|---|
The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Catechin; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Neuralgia | 2017 |
6 other study(ies) available for catechin and Nerve Pain
| Article | Year |
|---|---|
Antinociceptive effect of (-)-epicatechin in inflammatory and neuropathic pain in rats.
Topics: Analgesics; Animals; Carrageenan; Catechin; Cyclic GMP; Female; Hyperalgesia; Naloxone; Neuralgia; Nociception; Pain; Pain Management; Pain Measurement; Pain Perception; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Serotonin; Spinal Nerves | 2018 |
Epigallocatechin 3-gallate suppresses interleukin-1β-induced inflammatory responses in intervertebral disc cells in vitro and reduces radiculopathic pain in rats.
Topics: Adult; Animals; Catechin; Cells, Cultured; Female; Humans; Imidazoles; Inflammation; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; Intervertebral Disc; Intervertebral Disc Degeneration; Male; MAP Kinase Kinase 4; Matrix Metalloproteinases; Middle Aged; Neuralgia; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyridines; Radiculopathy; Rats; Rats, Sprague-Dawley | 2014 |
Nociceptive spinal cord neurons of laminae I-III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG).
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Catechin; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Immunohistochemistry; Male; Neuralgia; Neuroprotective Agents; Nociceptors; Oxidative Stress; Proto-Oncogene Proteins c-fos; Rats, Wistar; Spinal Cord; Touch | 2015 |
Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.
Topics: Animals; Catechin; Cell Membrane; Cytokines; Fatty Acid Synthase, Type I; Fatty Acids; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neuralgia; Pain; Pain Threshold; Peripheral Nerve Injuries; Spinal Cord Injuries | 2015 |
Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats.
Topics: Animals; Catechin; Chronic Disease; Constriction; Gene Expression Regulation; HMGB1 Protein; Injections, Spinal; Interleukin-10; Interleukin-1beta; Male; Neuralgia; NF-kappa B; Pain Threshold; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sciatic Nerve; Spinal Cord; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2012 |
Role of neuronal nitric oxide synthase in the antiallodynic effects of intrathecal EGCG in a neuropathic pain rat model.
Topics: Animals; Arginine; Catechin; Disease Models, Animal; Extremities; Hyperalgesia; Injections, Spinal; Ligation; Male; Neuralgia; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerves | 2012 |